Literature DB >> 934231

Letter: Cyproheptadine for pituitary disorders.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 934231     DOI： 10.1056/NEJM197608122950715

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

2.  Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma.

Authors:  T C Ooi; Y Twum-Barima
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

3.  Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro.

Authors:  M Ishibashi; T Yamaji
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

Review 4.  Cushing syndrome: current concepts of diagnosis and therapy.

Authors:  D M Cook; J W Kendall; R Jordan
Journal:  West J Med       Date:  1980-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.